5 insiders reported 15 Form 4 transactions for Inozyme Pharma, Inc. (INZY) over the past 18 months (most recent 2025-07-03). Recent activity: Winton Matthew (COO) Sell 21,743 shares, Treco Douglas A (CEO & Chairman) Sell 43,861 shares, Subramanian Sanjay (SVP, CFO & Head of BD) Sell 39,701 shares, Bolte Axel (Director) Sell 423,926 shares, Hopfner Robert Lorne (Director) Sell 2.9M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-03 | Winton Matthew | COO | Sell | 21,743 | $86,972 |
| 2025-07-03 | Treco Douglas A | CEO & Chairman | Sell | 43,861 | $175,444 |
| 2025-07-03 | Subramanian Sanjay | SVP, CFO & Head of BD | Sell | 39,701 | $158,804 |
| 2025-07-03 | Bolte Axel | Director | Sell | 423,926 | $1.7M |
| 2025-07-03 | Hopfner Robert Lorne | Director | Sell | 2.9M | $11.7M |
| 2025-07-03 | Hopfner Robert Lorne | Director | Sell | 1.6M | $6.3M |
| 2025-06-27 | Winton Matthew | COO | Buy | 14,355 | $10,623 |
| 2025-06-27 | Subramanian Sanjay | SVP, CFO & Head of BD | Buy | 6,813 | $5,042 |
| 2025-06-27 | Treco Douglas A | CEO & Chairman | Buy | 2,815 | $2,083 |
| 2025-05-20 | Bolte Axel | Director | Buy | 152,823 | $149,767 |
| 2025-05-20 | Bolte Axel | Director | Buy | 4,407 | $4,319 |
| 2025-04-03 | Treco Douglas A | CEO & Chairman | Buy | 25,000 | $0 |
| 2025-04-03 | Treco Douglas A | CEO & Chairman | Sell | 8,819 | $7,849 |
| 2025-04-02 | Winton Matthew | COO | Buy | 2,490 | $1,917 |
| 2025-04-02 | Subramanian Sanjay | SVP, CFO & Head of BD | Buy | 2,490 | $1,917 |
Source: SEC Form 4 filings · as of 2025-07-03
